(NASDAQ: COO) Cooper Companies's forecast annual revenue growth rate of 4.82% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.17%.
Cooper Companies's revenue in 2024 is $3,804,100,000.On average, 8 Wall Street analysts forecast COO's revenue for 2024 to be $775,820,410,111, with the lowest COO revenue forecast at $770,250,227,051, and the highest COO revenue forecast at $778,479,336,567. On average, 8 Wall Street analysts forecast COO's revenue for 2025 to be $832,928,080,116, with the lowest COO revenue forecast at $820,911,429,342, and the highest COO revenue forecast at $838,006,946,303.
In 2026, COO is forecast to generate $888,299,710,729 in revenue, with the lowest revenue forecast at $875,846,510,873 and the highest revenue forecast at $903,310,068,527.